{
    "Trade/Device Name(s)": [
        "EM40 Self-monitoring Blood Glucose System",
        "EM40 Pro Blood Glucose System",
        "EM40 Glucose Control Solution"
    ],
    "Submitter Information": "EPS Bio Technology Corp.",
    "510(k) Number": "K133389",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR"
    ],
    "Summary Letter Date": "April 15, 2014",
    "Summary Letter Received Date": "March 20, 2014",
    "Submission Date": "March 19, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for EM40 Self-monitoring and Pro Blood Glucose Systems for quantitative measurement of glucose in fresh capillary whole blood.",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from fingertip, palm, or forearm; control solution intended for quality control check of test result accuracy.",
    "fda_folder": "Clinical Chemistry"
}